Molecular Docking, Drug Likeness, and ADMET Analyses of Passiflora Compounds as P-Glycoprotein (P-gp) Inhibitor for the Treatment of Cancer
Crossref DOI link: https://doi.org/10.1007/s40495-020-00241-6
Published Online: 2020-09-18
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yalcin, Serap
Text and Data Mining valid from 2020-09-18
Version of Record valid from 2020-09-18
Article History
Accepted: 8 September 2020
First Online: 18 September 2020